Insiders · Profile

Reed Joshua

Director at Scholar Rock · Chief Financial Officer at Aldeyra Therapeutics. Filing since 5 Sep 2019. CIK 0001746541

Company
Date
Role
Action
Shares
Amount
Of holding
1 Jul 2026
Director
Sold on a plan
3,053
$164.07K
13.5%
29 May 2025
Director
Sold on a plan
5,400
$160.46K
25.6%
5 Sep 2019
Chief Financial Officer
Bought
3,200
$15.07K
9.8%
3 decisions on file.